Publication Rate and Journal Review Time of COVID-19–Related Research

TY - JOUR

T1 - Publication Rate and Journal Review Time of COVID-19–Related Research

AU - Putman, Michael S.

AU - Ruderman, Eric M.

AU - Niforatos, Joshua D.

N1 - Funding Information: Potential Competing Interests: Dr Ruderman reports grants from Amgen and Pfizer; and personal fees from AbbVie, Amgen, Janssen, Gilead, Lilly, Novartis, Sanofi/Genzyme, Scipher, and Pfizer outside the submitted work. Drs Putman and Niforatos have nothing to disclose.Grant Support: Dr Putman is supported in part by grant number T32 AR007611-13 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, which had no role in the design, analysis, or writing of this manuscript. Funding Information: Grant Support: Dr Putman is supported in part by grant number T32 AR007611-13 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases , which had no role in the design, analysis, or writing of this manuscript.

PY - 2020/10

Y1 - 2020/10

UR - http://www.scopus.com/inward/record.url?scp=85091649561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091649561&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2020.08.017

DO - 10.1016/j.mayocp.2020.08.017

M3 - Letter

C2 - 33012362

AN - SCOPUS:85091649561

SN - 0025-6196

VL - 95

SP - 2290

EP - 2291

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

IS - 10

ER -